Suppr超能文献

通气效率与心脏移植患者的选择。

Ventilatory efficiency and the selection of patients for heart transplantation.

机构信息

Department of Cardiology, Hospital Santa Cruz, Av. Prof Reynaldo dos Santos, Carnaxide, Portugal.

出版信息

Circ Heart Fail. 2010 May;3(3):378-86. doi: 10.1161/CIRCHEARTFAILURE.108.847392. Epub 2010 Feb 22.

Abstract

BACKGROUND

Ventilatory efficiency, assessed by the slope of minute ventilation (VE) versus carbon dioxide production (VCO(2)), is a powerful prognostic marker in patients with chronic heart failure. We hypothesized that VE/VCO(2) slope would be more accurate than the current listing criteria for heart transplantation (HTx) in identifying patients likely to derive a survival benefit from this intervention.

METHODS AND RESULTS

A total of 663 patients with chronic heart failure who underwent cardiopulmonary exercise testing were tracked for cardiac mortality and HTx. Ve/Vco(2) slope was the strongest independent predictor of mortality. Using a VE/VCO(2) slope threshold instead of the current exercise criteria would classify 39 more subjects as being high risk (196 versus 157), correctly identifying 19 more patients who died during follow-up (57 versus 38) and 16 others who underwent transplantation (52 versus 36). Unlike the current listing criteria for HTx, VE/VCO(2) slope provided significant discrimination between the 3-year survival of high- and low-risk patients and posttransplant patients selected from the International Society for Heart and Lung Transplantation registry. Reanalysis of survival data using death or HTx as the end point showed similar results.

CONCLUSIONS

VE/VCO(2) slope is more accurate than the current listing criteria for HTx in identifying patients likely to derive a survival benefit from HTx.

摘要

背景

通过分钟通气量(VE)与二氧化碳产生量(VCO(2))的斜率评估通气效率,是慢性心力衰竭患者强有力的预后标志物。我们假设 VE/VCO(2)斜率比目前的心脏移植(HTx)列入标准更能准确识别可能从这种干预中获益的生存的患者。

方法和结果

共 663 例慢性心力衰竭患者接受心肺运动测试,并对其进行心脏死亡率和 HTx 随访。VE/VCO(2)斜率是死亡率的最强独立预测因子。使用 VE/VCO(2)斜率阈值而不是当前的运动标准,将有 39 名更多的患者被归类为高危(196 例比 157 例),正确识别出 19 名在随访期间死亡的患者(57 例比 38 例)和 16 名接受移植的患者(52 例比 36 例)。与目前的 HTx 列入标准不同,VE/VCO(2)斜率在高危和低危患者以及从国际心肺移植协会登记处选择的移植后患者的 3 年生存率之间提供了显著的区分。使用死亡或 HTx 作为终点重新分析生存数据,得到了类似的结果。

结论

VE/VCO(2)斜率比目前的 HTx 列入标准更能准确识别可能从 HTx 中获益的患者。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验